Sign up
Quantellect · Analysts · Analyst Profile
Q Score Rank#429 of 449

Nathan Weinstein

Aegis Capital · Equity Research Analyst
ProvisionalRating since 2020No new ratings since Jul 2025

Analyst rating accuracy & track record

Nathan Weinstein is an equity research analyst at Aegis Capital. Quantellect has scored 22 of their stock calls across 13 companies. Their picks beat their sector 28% of the time over the next 12 months, and their price targets were reached 26% of the time within a year.

Win % vs sector
28%
PT Hit % (12mo)
26%
Avg sector-excess
−30.1%
Scored calls
22
Tickers
13
Tier
Provisional

Track record

Quantellect has scored 22 of Nathan Weinstein's stock calls across 13 companies, dating back to 2020. Their rated stocks beat their own sector 28% of the time over the next 12 months. On a typical call, a Weinstein pick returned −30.1% more than its sector over the following year.

Of the scored calls, 22 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ATAIATAI Life Sciences BV
Buy$8.00Jul 2025+65.0%Miss
EVGNEvogene
Buy$8.00Sep 2022−34.2%Miss
DRIODarioHealth Corp
Buy$15.00Aug 2022−44.8%Miss
STXSStereotaxis Inc
Buy$6.00Jul 2022−35.3%Miss
DRIODarioHealth Corp
Buy$20.00May 2022−48.7%Miss
ORMPOramed Pharmaceuticals Inc
Buy$30.00May 2022−25.6%Miss
MDWDMediwound Ltd
Buy$7.00Mar 2022−11.3%Miss
SCNIScinai Immunotherapeutics Ltd
Buy$7.00Jan 2022−84.7%Miss
DRIODarioHealth Corp
Buy$25.00Jan 2022−30.9%Miss
ORMPOramed Pharmaceuticals Inc
Buy$35.00Nov 2021−71.4%Miss
IINNInspira Technologies Oxy BHN Ltd
Buy$10.00Nov 2021−62.1%Miss
DRIODarioHealth Corp
Buy$28.00Aug 2021−55.8%Miss
ATAIATAI Life Sciences BV
Buy$27.00Aug 2021−71.4%Miss
ORMPOramed Pharmaceuticals Inc
Buy$20.00Jun 2021−75.7%Hit
SCYXScynexis Inc
Buy$35.00Jun 2021−84.9%Miss
SCYXScynexis Inc
Buy$40.00Apr 2021−74.5%Miss
DRIODarioHealth Corp
Buy$35.00Feb 2021−85.1%Miss
ORMPOramed Pharmaceuticals Inc
Buy$12.00Jan 2021+5.2%Hit
BMRABiomerica Inc
Buy$11.00Oct 2020−24.7%Miss
ICCCImmuCell Corporation
Buy$14.00Jul 2020+34.4%Miss
AMRNAmarin Corporation PLC
Buy$11.00May 2020−62.6%Miss
EKSOEkso Bionics Holdings Inc
Buy$15.00Apr 2020+27.7%Miss
Prev1Next
Go to

Nathan Weinstein: analyst track record FAQ

Is Nathan Weinstein a good stock analyst?

Yes, by track record. Nathan Weinstein ranks number 429 of 449 of the analysts Quantellect scores, with a Q Score of 0 out of 100. Past results do not guarantee future ones.

What is Nathan Weinstein's win rate?

Nathan Weinstein's win rate is 28%. Across 22 scored calls, their rated stocks beat their sector 28% of the time over the next 12 months. On a typical call they returned −30.1% more than the sector.

What stocks and sectors does Nathan Weinstein cover?

Nathan Weinstein covers 13 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Nathan Weinstein's price targets accurate?

Nathan Weinstein's price targets are reached within 12 months 26% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Nathan Weinstein's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Nathan Weinstein rank among Wall Street analysts?

Nathan Weinstein ranks number 429 of 449 by Q Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.